Quick Search


 

Result Summaries: zidovudine/lamivudine

ViiV
Study ID
   Phase    Title Summary (Download)
111950_5 n\a Fractures over time stratified by HIV infection and Antiretroviral Therapy (ART) exposure (0 citation(s)) Click here to download result summary.
112287 N/A Drug Use Investigation for Combivir tablet (HRD Cooperative Investigation) (0 citation(s)) Click here to download result summary.
112290 N/A Special Drug Use Investigation for Combivir tablet (Pregnancy) (HRD Cooperative Investigation) (0 citation(s)) Click here to download result summary.
112872_5 n\a HIV treatment and CVD events - Ingenix. Retrospective Database Analysis of Patients with Human Immunodeficiency Virus (HIV) Treatment and Cardiovascular Disease (CVD) Events (0 citation(s)) Click here to download result summary.
112877_7 N/A Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration (5 citation(s)) Click here to download result summary.
112878_7 N/A Diabetes Mellitus, Preexisting Coronary Heart Disease, and the Risk of Subsequent Coronary Heart Disease Events in Patients Infected With Human Immunodeficiency Virus (0 citation(s)) Click here to download result summary.
112885_5 N/A Antiretroviral Pregnancy Registry (APR)-Risk of birth defects associated with exposure to GSK HIV drugs during pregnancy (1 citation(s)) Click here to download result summary.
112887_5 N/A Studies using DAD - Effects of different interventions to improve ART-associated dyslipidemia (1 citation(s)) Click here to download result summary.
113039_5 N/A Studies using DAD - Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: Are different antiretroviral drugs associated with different lipid profiles? (1 citation(s)) Click here to download result summary.
113156_5 N/A Studies using the VA - Studies done under the Oversight Committee for the Evaluation of the metabolic complications of HAART (2 citation(s)) Click here to download result summary.
113329_5 n\a Lactic acid levels in children pre- and perinatally treated with antiretrovirals to prevent HIV transmission (Giaquinto; Hyperlactatemia in infants with in utero exposure to ZDV/3TC ) (2 citation(s)) Click here to download result summary.
CNAF3021 Phase 4 Long term follow-up of 2 triple combinations CombivirTM + Ziagen™ and Combivir™ + Viracept™ started in HIV-1 infected antiretroviral therapy naïve subjects within 2 years in study CNAF3007-Ecureuil. (0 citation(s)) Click here to download result summary.
COL30267 Phase 3 Initial title: Evaluation of efficacy and safety of combination of Combivir TM(AZT/3TC) and abacavir, in HIV-infected patients with an abacavir-susceptible phenotype and who had received Zerit ® (d4T) and Videx ® (ddl) as first-line treatment with or without non nucleosidic… (1 citation(s)) Click here to download result summary.
COL30527 Phase 1 The pharmacokinetics and bioequivalence of lamotrigine capsules and tablets, and effect of food on lamotrigine tablets. (0 citation(s)) Click here to download result summary.
NUCB3027 Phase 3 Phase III trial to compare the efficacy of the combination zidovudine/lamivudine taken either as a single tablet of a fixed-dose combination (zidovudine 300 mg/lamivudine 150 mg) twice daily, or as zidovudine (two 100 mg capsules, three times daily) and lamivudine (one 150 mg tablet, twice daily ... (0 citation(s)) Click here to download result summary.
NZTA1001 Phase 1 An Evaluation of the Bioequivalence of a Combined Formulated Tablet Compared to Epivir and Retrovir Administered Concurrently and the Effect of Food on Absorption (1 citation(s)) Click here to download result summary.
NZTA4001 Phase 4 A Randomized, Multicenter Study of EPIVIR 150mg BID, RETROVIR 200mg TID and a Protease Inhibitor Versus 3TC 150mg/ZDV 300mg Fixed-Dose Tablet Given BID with a Protease Inhibitor in HIV-1 Infected Subjects (2 citation(s)) Click here to download result summary.
NZTA4003 Phase 4 A Pharmacokinetic Evaluation of Methadone Following Co-administration with Combivir in Opiate-dependent Subjects (0 citation(s)) Click here to download result summary.
NZTA4007 Phase 3 A Phase IIIB, Open-Label, Pilot Study to Evaluate the Efficacy, Tolerability, and Health Care Resource Use in HIV-Infected Incarcerated Subjects Treated Twice Daily for 24 Weeks with COMBIVIR (Lamivudine 150mg/Zidovudine 300mg) plus ZIAGEN (Abacavir) 300mg. (1 citation(s)) Click here to download result summary.
ZDVB1003 Phase 1 A phase I study to evaluate the pharmacokinetics and safety of RETROVIR (zidovudine, ZDV) administered orally in combination with EPIVIR™ (lamivudine, 3TC) to HIV-1 infected pregnant women and their offspring. (1 citation(s)) Click here to download result summary.